Christian F. Guerrero-Juarez, Maksim V. Plikus
Index: 10.1016/j.stem.2017.05.003
Full Text: HTML
Activating triggers, selective markers, and the residual regenerative potential of scar-forming myofibroblasts are largely determined by their origin. In this issue ofCell Stem Cell, Schneider et al. report that bone marrow myofibroblasts derive from Gli1+mesenchymal stromal cells and that a Gli inhibitor targets them for elimination in mice and humans, ameliorating fibrosis.
|
ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Supp...
2017-07-13 [10.1016/j.stem.2017.06.004] |
|
Lineage Tracing: Papers and Progress
2017-07-06 [10.1016/j.stem.2017.06.015] |
|
Intestinal Enteroendocrine Lineage Cells Possess Homeostatic...
2017-07-06 [10.1016/j.stem.2017.06.014] |
|
Direct Neuronal Reprogramming: Achievements, Hurdles, and Ne...
2017-07-06 [10.1016/j.stem.2017.06.011] |
|
Making HSCs on Demand: Looking Ahead
2017-07-06 [10.1016/j.stem.2017.06.010] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved